CETONES-SFDT1 | ABBOTT | Diabetes | Ambispective Survey | Retrospective Study

CÉTONES is a project by ABBOTT Laboratories focused on identifying barriers to ketone self-monitoring in patients with type 1 diabetes (T1D), and describing subgroups of patients likely to use the new Freestyle Libre dual glucose and ketone sensor.

This study involves participants from the SFDT1 cohort, with Alsinova as the partnering CRO, matching data already collected within the study and distributing a new survey to assess knowledge of ketosis and diabetic ketoacidosis.

Survey distribution: Q2 2025

Results: Q3 2025

Role of Alsinova: study coordination, protocol and regulatory document drafting, data collection hosting, data management, biostatistical analysis, and medical writing.